Second malignancy risks after non-hodgkin's lymphoma and chronic lymphocytic leukemia: Differences by lymphoma subtype

Journal of Clinical Oncology

Volumn 28, Issue 33, 2010, Pages 4935-4944

  Morton, Lindsay M ^a   Curtis, Rochelle E ^a   Linet, Martha S ^a   Bluhm, Elizabeth C ^a   Tucker, Margaret A ^a   Caporaso, Neil ^a   Ries, Lynn A G ^a   Fraumeni Jr , Joseph F ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ACUTE LEUKEMIA; ADULT; AGED; ANUS CANCER; ARTICLE; CANCER REGISTRY; CANCER RISK; CANCER SURVIVOR; CHRONIC LYMPHATIC LEUKEMIA; COLON CANCER; FEMALE; FOLLICULAR LYMPHOMA; HODGKIN DISEASE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; KAPOSI SARCOMA; LARGE CELL LYMPHOMA; LUNG CANCER; MAJOR CLINICAL STUDY; MALE; MELANOMA; NONHODGKIN LYMPHOMA; PRIORITY JOURNAL; RISK ASSESSMENT; SALIVARY GLAND CANCER; SECOND CANCER; THYROID CANCER;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; INFANT; LEUKEMIA, LYMPHOCYTIC, CHRONIC, B-CELL; LYMPHOMA, AIDS-RELATED; LYMPHOMA, NON-HODGKIN; MALE; MIDDLE AGED; NEOPLASMS, SECOND PRIMARY; RISK;

EID: 79951867438     PISSN: 0732183X     EISSN: 15277755     Source Type: Journal    
DOI: 10.1200/JCO.2010.29.1112     Document Type: Article

References (58)

1. World Health Organization Classification of Tumours of Haematopoietic and Lymphoid Tissues. Lyon, France, IARC Press, 2008
2. DeVita VT Jr, Lawrence TS, Rosenberg SA. Cancer: Principles & Practice of Oncology (ed 8). Phildelphia, PA, Lippincott, Williams, & Wilkins, 2008
3. Surveillance, Epidemiology, and End Results (SEER) Program: SEER Stat Database: Incidence - SEER 13 Regs Limited-Use, November 2008 Submission (1992-2006). National Cancer Institute, Division of Cancer Control and Population Sciences, Surveillance Research Program, Cancer Statistics Branch, 2009
4. Coté TR, Biggar RJ, Rosenberg PS, et al: Non-Hodgkin's lymphoma among people with AIDS: Incidence, presentation and public health burden - AIDS/Cancer Study Group. Int J Cancer 73:645-650, 1997 (Pubitemid 127483058)
5. de Sanjose S, Benavente Y, Vajdic CM, et al: Hepatitis C and non-Hodgkin lymphoma among 4784 cases and 6269 controls from the International Lymphoma Epidemiology Consortium. Clin Gastroenterol Hepatol 6:451-458, 2008 (Pubitemid 351447318)
6. Morton LM, Wang SS, Cozen W, et al: Etiologic heterogeneity among non-Hodgkin lymphoma subtypes. Blood 112:5150-5160, 2008
7. Ekström Smedby K, Vajdic CM, Falster M, et al: Autoimmune disorders and risk of non-Hodgkin lymphoma subtypes: A pooled analysis within the InterLymph Consortium. Blood 111:4029-4038, 2008
8. Skibola CF, Bracci PM, Halperin E, et al: Genetic variants at 6p21.33 are associated with susceptibility to follicular lymphoma. Nat Genet 41:873-875, 2009
9. Skibola CF, Bracci PM, Nieters A, et al: Tumor necrosis factor (TNF) and lymphotoxin-alpha (LTA) polymorphisms and risk of non-Hodgkin lymphoma in the InterLymph Consortium. Am J Epidemiol 171:267-276, 2010
10. André M, Mounier N, Leleu X, et al: Second cancers and late toxicities after treatment of aggressive non-Hodgkin lymphoma with the ACVBP regimen: A GELA cohort study on 2837 patients. Blood 103:1222-1228, 2004 (Pubitemid 38168631)
11. Brennan P, Scélo G, Hemminki K, et al: Second primary cancers among 109 000 cases of non-Hodgkin's lymphoma. Br J Cancer 93:159-166, 2005 (Pubitemid 41078800)
12. Goggins WB, Finkelstein DM, Tsao H: Evidence for an association between cutaneous melanoma and non-Hodgkin lymphoma. Cancer 91:874-880, 2001 (Pubitemid 32173315)
13. Hemminki K, Lenner P, Sundquist J, et al: Risk of subsequent solid tumors after non-Hodgkin's lymphoma: Effect of diagnostic age and time since diagnosis. J Clin Oncol 26:1850-1857, 2008
14. Landgren O, Pfeiffer RM, Stewart L, et al: Risk of second malignant neoplasms among lymphoma patients with a family history of cancer. Int J Cancer 120:1099-1102, 2006
15. McKenna DB, Stockton D, Brewster DH, et al: Evidence for an association between cutaneous malignant melanoma and lymphoid malignancy: A population-based retrospective cohort study in Scotland. Br J Cancer 88:74-78, 2003 (Pubitemid 36241221)
16. McLaughlin P, Estey E, Glassman A, et al: Myelodysplasia and acute myeloid leukemia following therapy for indolent lymphoma with fludarabine, mitoxantrone, and dexamethasone (FND) plus rituximab and interferon alpha. Blood 105:4573-4575, 2005 (Pubitemid 40807273)
17. Moser EC, Noordijk EM, van Leeuwen FE, et al: Risk of second cancer after treatment of aggressive non-Hodgkin's lymphoma: An EORTC cohort study. Haematologica 91:1481-1488, 2006 (Pubitemid 44736114)
18. Mudie NY, Swerdlow AJ, Higgins CD, et al: Risk of second malignancy after non-Hodgkin's lymphoma: A British cohort study. J Clin Oncol 24:1568-1574, 2006 (Pubitemid 46638780)
19. Sacchi S, Marcheselli L, Bari A, et al: Secondary malignancies after treatment for indolent non-Hodgkin's lymphoma: A 16-year follow-up study. Haematologica 93:398-404, 2008 (Pubitemid 351398641)
20. Travis LB, Curtis RE, Glimelius B, et al: Bladder and kidney cancer following cyclophosphamide therapy for non-Hodgkin's lymphoma. J Natl Cancer Inst 87:524-530, 1995
21. Travis LB, Weeks J, Curtis RE, et al: Leukemia following low-dose total body irradiation and chemotherapy for non-Hodgkin's lymphoma. J Clin Oncol 14:565-571, 1996 (Pubitemid 26051022)
22. Tward JD, Wendland MM, Shrieve DC, et al: The risk of secondary malignancies over 30 years after the treatment of non-Hodgkin lymphoma. Cancer 107:108-115, 2006 (Pubitemid 43939037)
23. Callea V, Brugiatelli M, Stelitano C, et al: Incidence of second neoplasia in patients with B-cell chronic lymphocytic leukemia treated with chlorambucil maintenance chemotherapy. Leuk Lymphoma 47:2314-2320, 2006 (Pubitemid 44773213)
24. Cheson BD, Vena DA, Barrett J, et al: Second malignancies as a consequence of nucleoside analog therapy for chronic lymphoid leukemias. J Clin Oncol 17:2454-2460, 1999 (Pubitemid 29368245)
25. Mellemgaard A, Geisler CH, Storm HH: Risk of kidney cancer and other second solid malignancies in patients with chronic lymphocytic leukemia. Eur J Haematol 53:218-222, 1994 (Pubitemid 24347966)
26. Morrison VA, Rai KR, Peterson BL, et al: Therapy-related myeloid leukemias are observed in patients with chronic lymphocytic leukemia after treatment with fludarabine and chlorambucil: Results of an Intergroup Study, Cancer and Leukemia Group B 9011. J Clin Oncol 20:3878-3884, 2002
27. Robak T, Blonski JZ, Gora-Tybor J, et al: Second malignancies and Richter's syndrome in patients with chronic lymphocytic leukaemia treated with cladribine. Eur J Cancer 40:383-389, 2004 (Pubitemid 38121276)
28. Schöllkopf C, Rosendahl D, Rostgaard K, et al: Risk of second cancer after chronic lymphocytic leukemia. Int J Cancer 121:151-156, 2007 (Pubitemid 46753863)
29. Travis LB, Curtis RE, Hankey BF, et al: Second cancers in patients with chronic lymphocytic leukemia. J Natl Cancer Inst 84:1422-1427, 1992
30. Tsimberidou AM, Wen S, McLaughlin P, et al: Other malignancies in chronic lymphocytic leukemia/small lymphocytic lymphoma. J Clin Oncol 27:904-910, 2009
31. Clarke CA, Glaser SL: Population-based surveillance of HIV-associated cancers: Utility of cancer registry data. J Acquir Immune Defic Syndr 36:1083-1091, 2004 (Pubitemid 38989375)
32. Diamond C, Taylor TH, Im T, et al: How valid is using cancer registries data to identify acquired immunodeficiency syndrome-related non-Hodgkin's lymphoma? Cancer Causes Control 18:135-142, 2007
33. Fritz AG: International classification of diseases for oncology (ed 3). Geneva, Switzerland, World Health Organization, 2000
34. Morton LM, Turner JJ, Cerhan JR, et al: Proposed classification of lymphoid neoplasms for epidemiologic research from the Pathology Working Group of the International Lymphoma Epidemiology Consortium (InterLymph). Blood 110:695-708, 2007 (Pubitemid 47105409)
35. US Census Bureau, Population Division, Census 2000: Migration by sex and age for the population 5 years and over for the United States, regions, states, and Puerto Rico: 2000 (PHC-T-23). http://www.census.gov/population/www/cen2000/ briefs/phc-t23/index.html
36. Gribben JG: How I treat indolent lymphoma. Blood 109:4617-4626, 2007
37. Vidal L, Gafter-Gvili A, Leibovici L, et al: Rituximab maintenance for the treatment of patients with follicular lymphoma: Systematic review and metaanalysis of randomized trials. J Natl Cancer Inst 101:248-255, 2009
38. Dasanu CA: Intrinsic and treatment-related immune alterations in chronic lymphocytic leukaemia and their impact for clinical practice. Expert Opin Pharmacother 9:1481-1494, 2008
39. Landgren O, Albitar M, Ma W, et al: B-cell clones as early markers for chronic lymphocytic leukemia. N Engl J Med 360:659-667, 2009
40. Friedberg JW, Fisher RI: Diffuse large B-cell lymphoma. Hematol Oncol Clin North Am 22:941-952, ix, 2008
41. Chaturvedi AK, Pfeiffer RM, Chang L, et al: Elevated risk of lung cancer among people with AIDS. AIDS 21:207-213, 2007 (Pubitemid 46036929)
42. Grulich AE, van Leeuwen MT, Falster MO, et al: Incidence of cancers in people with HIV/AIDS compared with immunosuppressed transplant recipients: A meta-analysis. Lancet 370:59-67, 2007 (Pubitemid 47017468)
43. Rizzo JD, Curtis RE, Socié G, et al: Solid cancers after allogeneic hematopoietic cell transplantation. Blood 113:1175-1183, 2009
44. Engels EA: Inflammation in the development of lung cancer: Epidemiological evidence. Expert Rev Anticancer Ther 8:605-615, 2008
45. Reed JC, Kitada S, Kim Y, et al: Modulating apoptosis pathways in low-grade B-cell malignancies using biological response modifiers. Semin Oncol 29:10-24, 2002 (suppl 2) (Pubitemid 34171790)
46. Swerdlow AJ, Schoemaker MJ, Allerton R, et al: Lung cancer after Hodgkin's disease: A nested case-control study of the relation to treatment. J Clin Oncol 19:1610-1618, 2001 (Pubitemid 32230860)
47. Travis LB, Gospodarowicz M, Curtis RE, et al: Lung cancer following chemotherapy and radiotherapy for Hodgkin's disease. J Natl Cancer Inst 94:182-192, 2002 (Pubitemid 34162752)
48. Musolino A, Bozzetti C, Bonomini S, et al: Lung cancer in patients with chronic lymphocytic leukemia: Does the HER-2 oncogene play a role? Lung Cancer 50:419-420, 2005
49. Morton LM, Hartge P, Holford TR, et al. Cigarette smoking and risk of non-Hodgkin lymphoma: A pooled analysis from the International Lymphoma Epidemiology Consortium. Cancer Epidemiol Biomarkers Prev 14:925-933, 2005 (Pubitemid 40478558)
50. Richardson DB, Terschüren C, Pohlabeln H, et al: Temporal patterns of association between cigarette smoking and leukemia risk. Cancer Causes Control 19:43-50, 2008
51. Kricker A, Armstrong BK, Hughes AM, et al: Personal sun exposure and risk of non-Hodgkin lymphoma: A pooled analysis from the InterLymph Consortium. Int J Cancer 122:144-154, 2008 (Pubitemid 350209989)
52. Curtin JA, Fridlyand J, Kageshita T, et al: Distinct sets of genetic alterations in melanoma. N Engl J Med 353:2135-2147, 2005 (Pubitemid 41653105)
53. Goldin LR, Landgren O, McMaster ML, et al: Familial aggregation and heterogeneity of non-Hodgkin lymphoma in population-based samples. Cancer Epidemiol Biomarkers Prev 14:2402-2406, 2005 (Pubitemid 41437843)
54. Goldin LR, Pfeiffer RM, Gridley G, et al: Familial aggregation of Hodgkin lymphoma and related tumors. Cancer 100:1902-1908, 2004
55. Amini RM, Enblad G: Relationship between Hodgkin's and non-Hodgkin's lymphomas. Med Oncol 20:211-220, 2003
56. Tsimberidou AM, Keating MJ: Richter syndrome: Biology, incidence, and therapeutic strategies. Cancer 103:216-228, 2005
57. Engels EA, Biggar RJ, Hall HI, et al: Cancer risk in people infected with human immunodeficiency virus in the United States. Int J Cancer 123:187-194, 2008 (Pubitemid 351705208)
58. Chaturvedi AK, Madeleine MM, Biggar RJ, et al: Risk of human papillomavirus-associated cancers among persons with AIDS. J Natl Cancer Inst 101:1120-1130, 2009